T he liver, the organ primarily dedicated to digestion, detoxification, and synthesis of plasma proteins, is a site in which Ag-rich blood from the gastrointestinal tract mixes with lymphocytes emerging from the spleen. The harmless Ag from dietary proteins and commensal microflora is generally met with immune tolerance in this organ (1) . In contrast, liver-trophic pathogens provoke innate and adaptive immune reactions (2) . Liver grafts of many species are frequently accepted by their MHC-incompatible hosts and promote tolerance to additional donor organs transplanted along with the liver (3). Many hepatotropic pathogens, including immunologically important hepatitis B and C, evade immune clearance and cause chronic infections (4, 5) . The liver is also a site of tumor metastasis, and the malignant cells in this location appear to escape immune surveillance. Although the molecular mechanisms responsible for selective tolerogenic properties of the liver are not understood, several observations suggest that they depend on local Ag-processing and presentation pathways by professional and nonprofessional APCs residing in the liver.
Cell populations implicated in the induction/maintenance of hepatic tolerance include liver endothelial cells, or liver sinusoidal endothelial cells (LSECs), 3 Kupffer cells, liver dendritic cells, and hepatocytes (6 -8) . The parenchymal hepatocytes constitute ϳ80% of the total volume of the liver and are located directly below LSEC layer lining up the hepatic blood vessels (sinusoids). Because the blood flow through the sinusoids is slow and the LSEC layer is fenestrated and lacks a basement membrane, the parenchyma is in direct contact with a variety of blood-borne immune cells. Under normal in vivo conditions, exposure of hepatocytes to lymphocytes does not lead to liver damage, despite the fact that parenchymal cells synthesize and metabolize a variety of Ags that may be perceived as nonself by the immune system. Experimental studies conducted in model systems (7, 8) led to the hypothesis that hepatocytes act as specialized APCs and contribute to the induction of liver tolerance, either because they lack expression of important costimulatory molecules, such as CD80 and CD86, or because they are deficient/altered in their MHC Ag-presenting functions.
Although it is firmly established that liver parenchyma is devoid of class II MHC, the status of class I MHC on hepatocytes is uncertain. This issue is of primary interest as the majority of liver lymphocytes (activated CD8 ϩ T cells undergoing apoptosis in the liver, NK cells, NKT cells, and ␥␦ T cells) express class I MHCreactive receptors. Expression of class I MHC on parenchymal cells has been regarded generally as very low (9, 10) , based on a large number of predominantly immunohistochemical studies in mice and humans (11) (12) (13) . More recent reports (14, 15) have questioned the early conclusions but did not provide quantitative data, nor did they address the question whether hepatically expressed class I H chains are assembled into stable complexes by a classical, peptide-dependent class I Ag presentation pathway.
We have re-examined this long-standing controversy and found that hepatocytes express abundant, thermostable cell surface class I MHC. The assembly of hepatic MHC class I H chain, ␤ 2 -microglobulin (␤ 2 m) and the stabilizing ligands is dependent on the key components of the classical class I presentation pathway, TAP and tapasin (TPN). In healthy adult mice, the stoichiometric ratio of these components is altered in hepatocytes compared with splenocytes and may favor rapid loading of Ags under the conditions associated with IFN-␥ up-regulation.
Materials and Methods

Mice
All mice were 8-to 10-wk-old males of C57BL/6 (B6) and H-2 b haplotype backcrossed to B6 background. B6 and ␤ 2 m Ϫ/Ϫ mice were purchased from The Jackson Laboratory. K bϪ/Ϫ , K bϪ/Ϫ D bϪ/Ϫ , and TAP1 Ϫ/Ϫ mice were from Dr. J. Forman (University of Texas Southwestern Medical Center, Dallas, TX). These strains and TPN Ϫ/Ϫ mice have been described previously (16 -18) .
Isolation of primary hepatocytes and splenocytes
Hepatocytes were isolated according to a standard two-step perfusion protocol (19, 20) . Briefly, mice were anesthetized with i.p. administration of pentobarbital (50 mg/kg), the thoracic inferior vena cava was cannulated, and the portal vein was opened for drainage. The liver was sequentially perfused in situ with two solutions. The preperfusion solution was composed of solution A (136 mM NaCl, 5.3 mM KCl, 0.5 mM NaH 2 PO 4 , 0.4 mM Na 2 HPO 4 , 9.1 mM HEPES, and 4.1 mM NaHCO 3 (pH 7.4)) supplemented with 0.5 mM EGTA and 5 mM D-glucose and was administered for 6 min at a flow rate of 5 ml/min. The perfusion solution (solution A supplemented with 0.05% collagenase A (Sigma-Aldrich), 0.004% DNase I (Sigma-Aldrich), 5 mM CaCl 2 , 0.005% trypsin inhibitor (Sigma-Aldrich), and 1% bovine albumin (Sigma-Aldrich)) was administered for 6 -8 min at a flow rate of 5 ml/min. Perfused liver tissue was gently dispersed in a washing medium (William's medium E (Invitrogen Life Technologies) containing 2% FBS (Atlanta Biologicals)) and filtered through a nylon mesh. Viable hepatocytes were purified by three consecutive, low-speed centrifugations (35 ϫ g for 3 min at 4°C), followed by an additional centrifugation (75 ϫ g for 10 min at 4°C) on 50% Percoll gradient using a swing-out rotor. The purity and viability of hepatocytes were consistently Ͼ98% and Ͼ96%, respectively, as determined by morphological features, flow cytometry (negative for surface MHC class II I-A b and CD3), and trypan blue exclusion.
Splenocytes were prepared according to a standard protocol (21) .
Measurements of cell dimensions
The average geometric size of hepatocytes and splenocytes was determined using an inverted microscope (Olympus CK40; Olympus). Cell images were recorded with QuantityOne software (Bio-Rad). Perpendicular dimensions of cell width and length were measured on printed images with a caliper meter. Cell diameter (2r) was calculated as the mean of perpendicular dimensions. The mean diameters of hepatocytes and splenocytes were estimated as 22.4 Ϯ 3.0 and 6.7 Ϯ 0.9 m, respectively. Assuming that splenocytes and hepatocytes are spherical and taking into account the difference in their diameters, it is estimated that a hepatocyte cell surface area (4r 2 ) is 11.2ϫ larger than splenocyte surface, and hepatocyte volume (4/3 r 3 ) is 37.4ϫ larger than splenocyte volume.
Cell cultures
Freshly prepared hepatocytes were cultured in flasks precoated with type I collagen (Sigma-Aldrich) in DMEM:Ham's F-12 (1:1 v/v) supplemented with FBS, insulin, transferrin, dexamethasone, nicotinamide, L-ascorbic acid 2-phosphate, seleneous acid, and epidermal growth factor. Splenocytes were resuspended in RPMI 1640 medium supplemented with 10% FBS, 50 M 2-ME, 1% Glutamax I (Invitrogen Life Technologies) and 10 mM HEPES (complete medium). B3Z T hybridoma cells specific for OVA (SIINFEKL) peptide presented by K b were obtained from Dr. S. OstrandRosenberg (University of Maryland, College Park, MD).
RNA isolation, cDNA synthesis, and RT-PCR
Total cellular RNA was isolated with Tri-Reagent (Molecular Research Center). Integrity and standardized loading of RNA were monitored by visualization of ribosomal bands.
For cDNA synthesis, 1 g of RNA was primed with oligo(dT) 12-18 primer (Invitrogen Life Technologies), and the first-strand cDNA was synthesized by Omniscript reverse transcriptase (Qiagen) in a reaction mixture of 20 l. Semiquantitative amplification of cDNA was performed routinely in 25 l of PCR mixture containing 1-3 l of template, 0.4 M concentrations of the appropriate primer (Table I) , 200 -400 M concentrations of each dNTP, and 0.5-1.25 U of DNA polymerase. The PCR products were visualized in agarose gels with UV light, and their intensities were recorded using Gel-Doc (Bio-Rad) and quantitated with QuantityOne software. All RNA samples were free of genomic DNA contamination as judged by PCR.
The competitive RT-PCR strategy was designed on the basis of published methodology (22 A fixed amount of sample cDNA was coamplified with each of the titrated standards. PCR products were fractionated on 3% agarose gel stained with ethidium bromide, and the intensities of the staining were analyzed by QuantityOne software. The equivalence point was determined where the sample and ICS-amplified PCR bands read similar intensity. Concentration of gene-specific transcripts/ cDNA of a sample was extrapolated from the corresponding ICS titer.
Northern blotting
Probes for Northern blotting were constructed by cloning of PCR fragments amplified from B6 liver cDNA with primers specific for K b , ␤ 2 m, LMP2, LMP7, LMP10, TPN, proteasome activator (PA28)-␣, -␤, and GAPDH (Table I) . Plasmid pH2 d -4, containing class I exon 4, was received from Dr. K. F. Lindahl (University of Texas Southwestern Medical Center). All fragments were subcloned into HincII site of pBluescript KS vector. The identities of insert sequences were confirmed by DNA sequencing. The linearized plasmids were used as templates for in vitro syntheses of RNA probes. The antisense RNA probes were synthesized by T3 or T7 RNA polymerase (Promega) and labeled by random incorporation of Dig-11-UTP (Boehringer Mannheim) according to the manufacturer's instructions.
For Northern hybridizations, samples of total cellular RNA (10 g) were separated on 1% agarose gels containing 2.2 M formaldehyde. Blotted membranes were hybridized separately with specific probes in Dig Easy Hyb buffer (Boehringer Mannheim) at 68°C, followed by several washes under conditions of increasing stringency. The membranes were then incubated with anti-digoxigenin-alkaline phosphatase Ab (Boehringer Mannheim) and developed with the Dig Luminescent Detection system (Boehringer Mannheim). The chemiluminescent signals were recorded using BioMax film (Eastman Kodak). The intensity of signals was analyzed with QuantityOne software.
Western blotting
The protein levels of TAP1 and TPN in hepatocyte and splenocyte lysates were measured by Western blotting according to a published protocol (23) . Primary purified hepatocytes and splenocytes were prepared from B6, TAP Ϫ/Ϫ , and TPN Ϫ/Ϫ mice. The controls were cell lines derived from B6 embryo fibroblast (B6/WT3) (24), TAP1-deficient cells (FT1 Ϫ ) (25) , and TPN-deficient (TPN Ϫ/Ϫ ) fibroblast cells (18) . Known numbers of cells were lysed in 1% Nonidet P-40, and the postnuclear lysates were adjusted to the same protein concentration. For each sample, 2.3 g of protein were electrophoresed in a 7% Tris-acetate gel (Invitrogen Life Technologies).
The resolved proteins were transferred to a polyvinylidene difluoride membrane (Millipore). TAP1 and TPN were reacted with rabbit antiserum 503 (26) and hamster mAb 5D3 (27) , respectively. The bound Abs were detected with the species-appropriate biotinylated secondary Abs (Jackson ImmunoResearch Laboratories), followed by streptavidin-conjugated HRP (Zymed Laboratories). The signals were developed using an ECL system (Amersham Biosciences) and visualized after exposure to BioMax-MR film (Eastman Kodak). The intensities of the bands were quantitated using NIH Image software.
ELISA measurements of K b levels
The experimental approach was as described previously (28) . Purified hepatocytes (2 ϫ 10 6 cells/ml) and splenocytes (5 ϫ 10 7 cells/ml) were lysed with ice-cold lysis buffer containing 0.5% Nonidet P-40 (SigmaAldrich) and proteinase inhibitors (5 g/ml pepstatin A, 2 g/ml leupeptin, 2.5 mM benzamidine, 20 g/ml soybean trypsin inhibitor, 100 M PMSF, and 4 mM EDTA) in 0.2 M phosphate buffer (pH 7.0). To measure naturally synthesized, conformed K b or H chain K b that can be stabilized by K b -binding peptides, protein-matched aliquots of cell lysates were incubated with saturating concentrations of K b -binding peptide chicken OVA (SIINFEKL), a nonbinding peptide ANAAAAAAA (2N) or with no peptides. After overnight incubation on ice, cell lysates were transferred to 37°C (heat shock) for 4 h to allow unstabilized K b molecules to decay. The levels of conformed K b proteins were measured by a semiquantitative sandwich ELISA (28) .
Quantitative flow cytometry
One million splenocytes or 3 ϫ 10 4 hepatocytes were resuspended in 50 l of FACS buffer (PBS containing 0.1% BSA and 20 mM EDTA), incubated for 30 min on ice with saturating amounts of 2.4G2 Ab to block FcRs, followed by incubation with saturating amount of relevant mAbs. The mAbs to K b (Y3) and to ␤ 2 m (S19.8) were directly conjugated with FITC. D b was stained with an unconjugated mAb MC89, followed by secondary staining with F(abЈ) 2 of FITC-conjugated goat anti-mouse Igs (QIFI kit; DakoCytomation). Cells were analyzed by FACScan (BD Biosciences). The external calibration standards (QIFI kit; DakoCytomation) were used to establish a linear detection range of fluorescence intensity for both hepatocytes and splenocytes. Data analysis was performed with CellQuest software (BD Biosciences). Viable cells were gated according to their light scatter characteristics and propidium iodide exclusion. Geometric mean of logarithmic fluorescence intensity (GMFI) was recorded. A sample's specific GMFI (sGMFI) was calculated as: sGMFI ϭ GMFI (specific Ab) Ϫ GMFI (isotype control Ab).
Peptide-induced stabilization of surface K b
Hepatocytes were seeded at 1 ϫ 10 5 cells/cm 2 in flasks precoated with type I collagen and cultured at 37°C until cells adhered. The cold stabilization assays were performed using a simplified procedure of previously described protocols (28) . Briefly, hepatocytes and splenocytes (4 ϫ 10 6 cells/ ml) were incubated separately with 1 g/ml K b -specific OVA peptides, a control D b -restricted epitope of influenza nucleoprotein NP (ASNEN-METM) or with no peptides for 4 h at 22°C. Cells treated with peptides were incubated for additional 2 h at 37°C to denature unstabilized surface K b Ags, whereas cells that did not receive peptides were kept at 4°C. After harvesting, cells were stained with Y3-FITC and analyzed by flow cytometry.
In situ staining of hepatic sinusoidal membrane
The liver was perfused in situ with the preperfusion solution for 3 min at 37°C, then for 10 min at 4°C. Hepatic hilar vessels were clipped to close the drainage. The liver was perfused for 15 min with 1-2 ml of cold FACS buffer containing FcR blocker (2.4G2), followed by 30 min of incubation with 1-2 ml of cold FACS buffer containing saturating amounts of Y3-biotin or isotype control Abs at 4°C. Drainage was then opened, and standard collagenase perfusions were conducted. After centrifugations and washes, purified hepatocytes were incubated with streptavidin-R-PE (BioSource International) for 30 min on ice, washed three times, and analyzed for surface K b expression by flow cytometry.
Induction of MHC class I by IFN-␥ and Listeria monocytogenes infection
For in vitro induction of class I MHC, purified hepatocytes were cultured for 2 days with the hepatocyte culture medium in the presence or absence of 20 U/ml mouse rIFN-␥ (Sigma-Aldrich). L. monocytogenes infection was performed according to a published protocol (29) . L. monocytogenes 10403 serotype 1 was obtained from Dr. J. Forman. Bacteria were grown on brain-heart infusion agar plates (Difco). The LD 50 for B6 mice is 2 ϫ 10 4 bacteria (29) . B6 mice were injected with 2 ϫ 10 3 bacteria in 200 l of PBS or with PBS alone through tail vein. The hepatocytes and splenocytes were isolated and analyzed at days 3 and 5.
Results
Hepatocytes express high levels of class I MHC Ags
The status of class I MHC expression levels on parenchymal liver cells is controversial, and the extent to which these cells use the 
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classical, TAP-dependent class I presentation pathway is not currently known. To address these issues, we set out to compare class I MHC expression of hepatocytes and splenocytes from B6 mice. Because these two cell types differ in size, surface, and biological properties, several independent assays were performed to evaluate the steady-state class I levels in these two backgrounds. Cell surface expression of classical MHC class I (class Ia) was evaluated first by quantitative flow cytometry using saturating amounts of mAbs recognizing K b (Y3) and D b (MC89). The cumulative levels of surface-displayed class I Ags (class Ia and the nonclassical class Ib, encoded by Q, T, and M loci of MHC) were evaluated with a ␤ 2 m-specific mAb (19.8) . To adjust for the differences in cell size and autofluorescence between hepatocytes and splenocytes, commercial calibration standards were included in each experiment and linear fluorescence detection curves were established. Single-cell suspensions of freshly isolated hepatic and splenic cells were analyzed under the same conditions of acquisition, and their fluorescence intensities were measured within the linear detection range (Fig. 1A) . In situ, liver hepatocytes assume a hexahedron-like shape. Onethird of their surfaces face into the sinusoidal spaces of Disse, whereas other surfaces contact basolateral and bile canalicular membranes. The sinusoidal membranes are the only surfaces exposed to lymphocytes and molecules circulating in blood. We took advantage of this property to assess whether the sinusoidal surfaces of hepatocytes express class I Ags in situ. Before standard perfusion, the liver was incubated with FcR-blocking Ab followed by biotinylated anti-K b Y3 mAb. The liver structures were then disrupted by standard collagenase perfusion and hepatocytes were purified. The single-cell suspension of prestained hepatocytes was then exposed to secondary streptavidin-PE conjugate and analyzed by FACS, along with conventionally ex vivo-stained, purified hepatocytes. The results in Fig. 1B are consistent with the interpretation that hepatocytes in situ are highly positive for K b and that the level of staining of these cells (ϳ30% of the level observed with ex vivo-stained cells) is proportional to the area predicted to interact with the sinusoidally infused anti-K b mAb. The data presented above bear on the levels of class I MHC detectable by specific Ab on the cell surface. Because cells may differ in their ability to transport MHC out of the endoplasmic reticulum (ER)/Golgi, K b -specific ELISA was performed on total cell lysates, as described previously (28) . This two Ab-based, class I capture assay quantitates total conformationally stable, intracellular, and cell surface-associated class I. The results, summarized in Fig. 1C , indicate that the concentration of conformed K b in hepatocytes is close to 70 -80% of the concentration in splenic lysate(s) per protein unit. After adjusting for differences in volume and surface of cells, this estimate indicates that the proportions of surface and intracellular K b are comparable (within the limits of the technique used) in the two cell types. The specificity of the assay was demonstrated by lack of detectable K b signal in cell lysates of the control K bϪ/Ϫ D bϪ/Ϫ knockout mice. To complement these assays, we tested whether purified hepatocytes express sufficient levels of class I MHC to present exogenously added Ag-peptide to the OVA-specific B3Z T cell hybridoma (Fig. 1D) . In this experimental system, stimulation of the hybridoma is solely dependent on the interaction of the TCR with OVA peptides presented by K b (31) . Graded concentrations of K b -binding OVA peptide (SIINFEKL) and D b -binding, nonactivating NP peptide (ASNENMETM) were incubated with equal numbers of hepatocytes and splenocytes from B6 and K bϪ/Ϫ mutant mice. Both B6 hepatocytes and splenocytes stimulated B3Z in a K b -specific and peptide dose-dependent fashion with hepatocytes appearing to be better stimulators on a per cell basis. The latter observation cannot be interpreted strictly in terms of MHC density as other parameters, distinguishing the surfaces of the presenting cell types, may influence the activation of the hybridoma via TCR.
Transcriptional studies further confirmed that hepatocytes and splenocytes synthesize comparably high concentrations (within a factor of 2) of steady-state levels of total, H chain class Ia/class Ib, and L chain ␤ 2 m. This is documented by Northern blot analysis ( Fig. 2) with a probe specific for ␤ 2 m and two probes reactive with class Ia/class Ib mRNAs: "␣3," hybridizing with the conserved exon 4 of all class I and "K b ," detecting K b transcripts, and, to a lesser extent, other homologous class Ia/b transcripts. An independent approach, quantitative RT-PCR (data not shown), gave consistent estimates: the concentrations of K b -specific transcripts appeared equimolar in the lysates of both cell types per unit of total RNA; the concentration of D b mRNA was 2-to 4-fold lower in hepatocytes, depending on the experimental conditions. The results summarized above provide formal evidence against the notion that hepatocytes are severely deficient in class I MHC.
Stoichiometry of gene products participating in class I MHC assembly is different in hepatocytes and splenocytes
Mature class Ia MHC is delivered to the cell surface after its three components: H chain, ␤ 2 m, and peptide are assembled in the ER. This process is dependent on a number of proteins participating in peptide generation (proteasome and its components LMP2, LMP7, LMP10, and PA28␣ and -␤), peptide transport into the ER (TAP1 and TAP2), stabilization of the class I peptide-loading complex, and class I assembly (TPN) (32) . Because the functional properties of class I MHC can be modified in response to changes in the Ag presentation pathway, it is of interest to examine if class I assembly operates similarly in hepatocytes and splenocytes.
The results of Northern hybridization and quantitative RT-PCR presented in Fig. 3 show that the lysate concentrations of the steady-state transcripts of several components of the Ag-processing and presentation pathway differed between hepatocytes and splenocytes: TAP1 and TAP2 were reduced in liver cells ϳ10-and ϳ5-fold, respectively, TPN 2.9-to 4-fold, LMP2 ϳ5.5-fold, LMP7 ϳ5.4-to 6.6-fold, LMP10 ϳ1.8-fold, and PA28␣, PA28␤ ϳ2.5-and ϳ4.2-fold, respectively. The relative reduction at the mRNA level was confirmed at the protein level by quantitating steady-state levels of TAP1 and TPN proteins by Western blotting hybridization (Fig. 4) . The results demonstrated ϳ7.2-and 6.5-fold lower concentration of these two proteins, respectively, in liver cell lysates. The data are consistent, within the limits of the techniques used, with our estimates derived from transcriptional analyses and confirm reports that the levels of the components of the class I Ag presentation pathway are regulated at the level of transcription (9) .
Class I MHC on hepatocytes are not empty
Given the relative excess of the hepatic class Ia H chain and ␤ 2 m over the components of class I assembly, one could speculate that peptides destined for K b and D b are severely limiting in liver cells. One consequence of such a scenario would be a scarcity of thermostable conformed class I complexes and excess of denatured thermolabile class I. Thermolabile, empty class I molecules that escape degradation in the ER, can be detected in the lysates by stabilization with exogenous synthetic peptides, followed by staining with Ab specific for the conformed class I (28). We addressed this prediction by testing whether K b from B6 liver lysates and splenic lysates are differentially stabilized with exogenously supplied, K b -binding (OVA) peptides under conditions of a heat shock at 37°C (Fig. 5) . The hepatic K b , just like their splenic counterparts, were stable at 37°C and did not respond to the stabilizing OVA peptide by a detectable enhancement of their expression levels. As a control, we demonstrated that this temperature is sufficient to destabilize empty TAP Ϫ/Ϫ splenic K b exposed to nonbinding 2N peptides but is well tolerated by OVA peptide-stabilized K b from the same cells. The concentrations of the conformed K b , detected in the lysates of both cell types, were also similar, in agreement with the data in Fig. 1C . These observations are consistent with the notion that stable K b associates intracellularly with endogenous peptide ligands and that this complex formation is similarly efficient in both cell types. Similar conclusions were reached using flow cytometry to probe for conformation of cell surface expressed K b (Fig. 6 and data not shown) . Display of thermostable class Ia on hepatocytes could be explained either by postulating that hepatocytes use the classical class I processing and presentation pathway more efficiently than splenocytes or, alternatively, that they rely on a different mechanism for peptide/ligand delivery and for trimer formation. To address the latter point, we tested if mice deficient in the components of the classical pathway, TAP Ϫ/Ϫ and TPN Ϫ/Ϫ , display stable class I MHC on liver cells. The results in Fig. 7 indicate that both mutations lead to the hepatic loss of surface K b , comparable to the loss observed in fully class I-negative, ␤ 2 m-deficient mice. Thus, we conclude that assembly of class I in hepatocytes is predominantly TAP and TPN assisted, despite their reduced availability in normal parenchymal cells.
Hepatocytes use reduced levels of TAP and TPN to assemble mature, stable class I
Interestingly, the phenotypes of TPN Ϫ/Ϫ hepatic and splenic cells assessed by flow cytometry (Fig. 7) differ in that the mutant liver cells appear fully negative for K b (reduced to background level), whereas the mutant splenic cells express K b levels intermediate between TAP
Ϫ/Ϫ and fully functional B6 lymphocytes. The partial expression of K b at the surface of TPN Ϫ/Ϫ cells is thought to result from the assembly and display of this class I loaded with lowaffinity peptides (18) . To assess if K b on TPN Ϫ/Ϫ hepatocytes is indeed absent at the cell surface or is simply denatured due to the loss of weakly binding peptides at 37°C, we pulsed hepatocytes and splenocytes with saturating amounts of K b -binding OVA peptide, predicted "to rescue" cell surface expression of K b . Indeed, this approach allowed enhanced detection of conformed K b on the ), were included as the negative controls. Protein-matched samples were resolved by electrophoresis, blotted, and reacted with TAP1-specific rabbit antiserum 503 (26) and TPN-specific hamster mAb 5D3 (27) . (Fig. 6) . One interpretation of this result is that the altered phenotype of hepatic TPN Ϫ/Ϫ cells is due to the failure of the residual TAP machinery to deliver a sufficient quantity of peptides into the ER. Because TPN has a dual function as a chaperone in folding and as an enhancer of TAP peptide transport activity (28, 33) , its absence may depress already low TAP activity in hepatocytes and produce a phenotype of a severely impaired mutant, such as might be predicted for a double TPN Ϫ/Ϫ TAP Ϫ/Ϫ mutation. Taken together, these results indicate that peptide loading in hepatocytes occurs at, or just below, the threshold levels necessary to stabilize the presynthesized class I H chain that eventually reach the cell surface.
What is the impact of infection or inflammation on the components of the class I Ag-processing and presentation pathway? We performed controlled experiments with cultured purified hepatocytes treated with IFN-␥, a cytokine that is known to up-regulate many genes in the class I presentation pathway and is produced at high levels during pathogen exposure. A similar gene expression pattern was detected in hepatocytes from mice infected with L. monocytogenes, an intracellular bacterium that promotes strong innate and adaptive immune responses (34) . Surface display of K b (sGMFI) was enhanced upon infection by a factor of 2.1 Ϯ 0.4 (data not shown), whereas transcription of the components of the peptide-loading pathway was generally induced to a greater degree (ϳ8-fold for TAP1, ϳ3-fold for TAP2, ϳ4-fold for TPN, and ϳ6-fold for LMP7; data not shown).
Thus, we conclude that inflammation or infection in the liver promotes a preferential stimulation of the components of Ag-processing and presentation, a change in the preexisting stoichiometry of class I MHC components in the ER and enhanced production/ loading of peptides derived from the newly degraded proteins.
Discussion
Although MHC class I expression is frequently described as "ubiquitous," individual cell types differ widely in the density of class I complexes displayed on their cell surfaces. Hemopoietic cells express normally the highest levels of class I, whereas most cells in immunologically privileged sites are nearly devoid of these Ags. Other cell types fall between these two extremes (35, 36) . In addition, some cells, particularly Ag-presenting dendritic cells and endothelial cells, regulate surface levels of class I according to their maturation state and in response to various cytokines and/or inflammatory signals (37, 38) .
Because the surface levels of class I correlate with the efficiency with which CTLs and NK cells recognize class I/peptide complexes, the cellular MHC status has become one of the criteria for predicting the immunological fate of cells coming into contact with class I-restricted lymphocytes. For example, it has been proposed that viral persistence in MHC-negative neurons is due to the lack of Ag-presenting capacity of target cells and their consequent invisibility to CTLs (39) . Accordingly, liver tolerance, among many other hypotheses, has been attributed to the absence of MHC class I on hepatocytes or, conversely, to tolerogenic effects of hepatic Ag presentation via MHC class I (7, 8) . Because of the difficulties in fractionation of hepatocytes, the great majority of the past experiments used immunochemical staining of whole liver sections to evaluate MHC levels. In each case when this approach was used, healthy parenchymal cells appeared nearly negative for class I (11, 13, 35) .
We had originally undertaken our investigation to identify the molecular mechanisms responsible for low MHC class I on normal hepatic cells. Instead, we found that hepatocytes in situ, or immediately after purification, express abundant and conformationally stable class I complexes approaching in cell surface density the levels of MHC on splenic lymphocytes.
One explanation that could account for the discrepancy between our conclusions and the historical reports is that purified hepatocytes may undergo reprogramming of gene expression immediately after dissociation and acquire the ability to display MHC class I ex vivo. Several lines of evidence argue against this possibility. First, class I transcription declines rather than increases, in cultured hepatic cells (Ref. 7 and our unpublished observations). Second, we examined hepatic sinusoidal membranes in situ and detected high levels of class I by flow cytometry. Third, ELISA protein measurements and transcript measurements performed on lysates from intact unfractionated liver (where hepatocytes constitute Ͼ80% of total volume) gave estimates of class I abundance comparable to those seen with purified, dissociated hepatocytes (our unpublished observations). Thus, we propose that immunochemical methods used in the past underestimated expression levels of class I on hepatocytes. Our data are in agreement with Skoskiewicz et al. (35) , who measured concentrations of K k protein in total liver lysates of B10.BR mice by absorption assay, and found it to be comparable to concentrations of K k in total spleen lysates. In addition, our estimates of H chain and ␤ 2 m transcript levels in isolated hepatocytes are consistent with the studies concluding that an intact liver synthesizes abundant class I MHC mRNAs (40, 41) .
During the course of our investigation, we noted that hepatic cells harbor reduced concentrations of transcripts and proteins required for peptide loading, relative to other cells such as splenocytes. Surprisingly, despite the apparent "deficiencies" of TAP1, TAP2, LMP7, LMP10, PA28␣, -␤, as well as TPN products in hepatic cells, MHC class I complexes from both cell types contain similar fractions of thermostable (peptide-loaded) complexes per unit of lysate volume. Furthermore, experiments with liver and spleen cells from TAP Ϫ/Ϫ and TPN Ϫ/Ϫ mice indicated that surface class I display in both cell types is dependent on an intact classical class I Ag presentation pathway. Thus, we hypothesize that the unique architecture and physiology of hepatocytes and their ER compartments helps to compensate for the relative scarcity of peptide delivery machinery.
Because the liver is a site of many viral, bacterial, and parasitic infections, it was of interest to examine how conditions stimulating Ag presentation affect hepatic class I MHC. We found that purified hepatocytes treated with IFN-␥ ex vivo or hepatocytes exposed to L. monocytogenes infection in vivo up-regulated mRNA and surface expression of K b Ͻ2-fold, whereas components of the Ag presentation pathway, TAP1, TAP2, TPN, and proteasome subunits, were induced to a greater degree (up to 10-fold). This discoordinate response would be predicted to selectively enhance production of MHC ligands and their loading into class I grooves. Consequently, immunostimulatory conditions such as those described here or during acute phase response (42) will result in preferential binding of H chain/␤ 2 m to newly generated peptides, rather than in elevation of surface MHC class I. This mechanism may be responsible for enhanced CTL recognition of viral epitopes in IFN-␥-treated liver cells (13) .
In summary, we have shown here that MHC class I complexes are assembled in hepatocytes in much the same way as in splenocytes. Similarly, high levels of stable class I trimers are displayed on the surface of both cell types. Therefore, hepatocytes should be competent to interact with lymphocytes via class I receptors and may modulate functions of NK and T cells during liver specific interactions (15, 43) .
